Barclays Maintains Equal-Weight on CME Gr, Raises Price Target to $231
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Benjamin Budish maintains an Equal-Weight rating on CME Group (NASDAQ:CME) and raises the price target from $219 to $231.
October 24, 2024 | 12:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays analyst Benjamin Budish has maintained an Equal-Weight rating on CME Group and increased the price target from $219 to $231, indicating a positive outlook.
The increase in price target from $219 to $231 by Barclays suggests a positive outlook for CME Group, which could lead to a short-term increase in stock price. The maintained Equal-Weight rating indicates a balanced view, but the raised target price is a positive signal.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100